Adial Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$0
$0
$0
$0
Gross Profit
EBITDA
-2,001
-1,885
-1,763
-1,882
EBIT
-2,001
-1,885
-1,764
-1,882
Net Income
-2,022
-1,996
-1,793
-1,958
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,612
-1,324
-1,833
-1,749
Cash
4,584
5,881
4,606
5,914
Basic Shares
1,370
1,111
886
424

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-60
EBITDA
-7,798
-8,283
-7,001
-10,858
EBIT
-7,799
-8,284
-7,001
-10,859
Net Income
-7,977
-13,197
-7,001
-12,731
Net Change In Cash
0
0
0
0
Free Cash Flow
-6,492
-6,922
-6,806
-11,185
Cash
5,881
3,750
2,827
4,001
Basic Shares
668
743
56
42

Earnings Calls

QuarterEPS
2026-03-31
-$1.48
2025-12-31
-$11.48
2025-09-30
-$0.08
2025-06-30
-$0.18